Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05038163 · ClinicalTrials.gov registry record · NA
Are Sugar-Sweetened Beverage Information Labels Well-Targeted
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 5,845
- Enrollment target
NCT05038163: Completed NA study, sponsored by National Bureau of Economic Research.
NCT05038163 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 5,845 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (317% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05038163, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,845 participants
- Enrollment target
Study Summary
We will study the extent to which soft drink information labels -- designed to curb unhealthy consumption -- are well-targeted to the most biased consumers.The study team will deploy novel methods for evaluating the targeting properties of information labels via an incentive-compatible online shopping experiment. At a high-level, we will ask whether the treatment effects of the information labels are concentrated on individuals with the biggest self-control problems and with the least knowledge of nutrition. We will first use the methodology from Allcott et al. (2019) to estimate the internality for each participant. We will then have participants make shopping decisions for soft drinks, first absent any information labels and then, for those not in the control group, in the presence of an information label. The within-subject design of the soft drinks experiment will allow us to estimate how the effects of the labels covary with consumers' internalities, and thus to determine whether the labels are well-targeted.
Primary Outcome
How much consumers like, or are willing to pay for, sugar-sweetened beverages when compared to a sugar-free alternative. The survey instrument uses a multiple price list (MPL) to elicit each respondent's relative willingness to pay (WTP) for the sugary drink vs. the non-sugary alternative, a standard methodology in the economics literature where consumers answer a series of questions about whether they would prefer to buy a sugar-sweetened beverage at price X or a sugar-free alternative at price
Interventions
- OTHER Nutrition Facts
- OTHER Text Warning
- OTHER Graphic Warning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,845 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2021-12-22 |
| Phase | NA |
What the finished NCT05038163 record still lists
NCT05038163 is an interventional study that assigns participants to a tested intervention. Its 5,845 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (317% higher).
The record links to 0 conditions, and to 3 interventions - of which Nutrition Facts is the first listed.
NCT05038163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05038163 about?
NCT05038163 is a clinical study titled "Are Sugar-Sweetened Beverage Information Labels Well-Targeted". We will study the extent to which soft drink information labels -- designed to curb unhealthy consumption -- are well-targeted to the most biased consumers.The study team will deploy novel methods for evaluating the targeting properties of information labels via an incentive-compatible online shoppi...
What is the current status of trial NCT05038163?
This trial is currently completed. It is a NA study. The enrollment target is 5,845 participants. The study started on 2021-10-18. Estimated completion is 2021-12-22.
What interventions are being tested in trial NCT05038163?
The interventions under investigation include: Nutrition Facts (OTHER), Text Warning (OTHER), Graphic Warning (OTHER).
Who is sponsoring clinical trial NCT05038163?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05038163's enrollment target sits among peer trials
5,845 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- NCT06192511 · 5,980 participants · NA
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI